Costs and health impact of delayed implementation of a national hepatitis B treatment program in China.
J Glob Health
; 12: 04043, 2022 Jul 08.
Article
in En
| MEDLINE
| ID: mdl-35796158
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Hepatitis B
Type of study:
Health_economic_evaluation
/
Sysrev_observational_studies
Aspects:
Implementation_research
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Glob Health
Year:
2022
Document type:
Article
Affiliation country:
United States